SELLAS Life Sciences Group, Inc. (SLS)

4.55 -0.19 (-4.01%) USD  |  NASDAQ  |  Feb 25, 16:00
4.64 +0.09 (+1.98%) After-Hours: 06:55
More

SELLAS Life Sciences Group Stock Based Compensation (Annual)

Stock Based Compensation (Annual) Chart

View Stock Based Compensation (Annual) for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (Annual) Range, Past 5 Years

View Stock Based Compensation (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (Annual) Benchmarks

View Stock Based Compensation (Annual) Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. --
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade